Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fda.gov

What's New: Drugs RSS Feed

Get the latest updates from What's New: Drugs RSS Feed directly as they happen.

Follow now 919 followers

Latest posts

Last updated 2 days ago

Drug Trials Snapshot: HYRNUO

2 days ago

HYRNUO is a tyrosine-kinase inhibitor that is indicated for the treatment of...

Drug Trials Snapshots: EXDENSUR

2 days ago

Drug Trials Snapshots: EXDENSUR

ULTRA ADVANC3 and ULTRA ADVANC3 GOLD may be harmful due to hidden drug ingredients

3 days ago

The Food and Drug Administration is advising consumers not to purchase or...

Drug Trials Snapshots: KOMZIFTI

3 days ago

Drug Trials Snapshots: KOMZIFTI

Online Advisory Letters

3 days ago

Online Advisory Letters

FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung cancer

3 days ago

FDA granted accelerated approval to zongertinib, a kinase inhibitor, for an expanded...

Why Protecting Confidential Information is Key to the FDA’s "Gold Standard"

3 days ago

The FDA must maintain a delicate balance: being a model of openness...

Internet Pharmacy Warning Letters

3 days ago

Rogue online pharmacies offer potentially dangerous prescription drugs to U.S. consumers. FDA...

Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act

3 days ago

Section 505B(d)(1) requires FDA to send a PREA Non-Compliance letter to sponsors...

Withdrawn | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals

4 days ago

This listing includes accelerated approvals (AAs) for non-malignant hematological, neurological, and other...

Ongoing | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals

4 days ago

Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint

Accelerated Approval Program

4 days ago

To allow for earlier approval of drugs that treat serious conditions and...